Insufficient evidence to conclude whether anti-tumor necrosis factor therapy increases the risk of lymphoma in Crohn's disease

Clin Gastroenterol Hepatol. 2009 Oct;7(10):1139. doi: 10.1016/j.cgh.2009.05.012. Epub 2009 May 22.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Crohn Disease / complications*
  • Crohn Disease / drug therapy*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lymphoma / chemically induced*
  • Risk Assessment
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Immunologic Factors
  • Tumor Necrosis Factor-alpha